Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
61.8M
-
Number of holders
-
59
-
Total 13F shares, excl. options
-
27.1M
-
Shares change
-
+2M
-
Total reported value, excl. options
-
$334M
-
Value change
-
+$25M
-
Put/Call ratio
-
1
-
Number of buys
-
39
-
Number of sells
-
-17
-
Price
-
$12.35
Significant Holders of Aura Biosciences, Inc. - Common Stock (AURA) as of Q2 2023
66 filings reported holding AURA - Aura Biosciences, Inc. - Common Stock as of Q2 2023.
Aura Biosciences, Inc. - Common Stock (AURA) has 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.1M shares
of 61.8M outstanding shares and own 43.81% of the company stock.
Largest 10 shareholders include Matrix Capital Management Company, LP (5.36M shares), Medicxi Ventures Management (Jersey) Ltd (3.04M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.94M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.71M shares), CITADEL ADVISORS LLC (2.46M shares), BlackRock Inc. (1.87M shares), VANGUARD GROUP INC (1.03M shares), GOLDMAN SACHS GROUP INC (1.03M shares), Rock Springs Capital Management LP (1.02M shares), and Nantahala Capital Management, LLC (803K shares).
This table shows the top 59 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.